{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:23:28Z","timestamp":1774790608942,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jbspin.2009.10.011","type":"journal-article","created":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T09:08:38Z","timestamp":1262336918000},"page":"102-107","source":"Crossref","is-referenced-by-count":76,"title":["Anti-IL-1 molecules: New comers and new indications"],"prefix":"10.1016","volume":"77","author":[{"given":"Anna","family":"Molt\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2009.10.011_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJM199301143280207","article-title":"The role of interleukin-1 in disease","volume":"328","author":"Dinarello","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.10.011_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2009.10.011_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.61.11.960","article-title":"Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases","volume":"61","author":"Hallegua","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.011_bib4","first-page":"204","article-title":"Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat","volume":"172","author":"Rivier","year":"1993","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.jbspin.2009.10.011_bib5","first-page":"416","article-title":"Interleukin-l and bone metabolism: a review","volume":"64","author":"Tatakis","year":"1993","journal-title":"J Peridontol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.1780330302","article-title":"Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood.V75.12.2328.2328","article-title":"Macrophage control of normal and leukemic erythropoiesis. Identification of the macrophage derived erythroid suppressing activity as interleukin-l and the mediator of its effect as tumor necrosis factor","volume":"75","author":"Furmanski","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2009.10.011_bib8","first-page":"21","article-title":"Is there a rationale for combined TNF and IL-1 blocking in arthritis","volume":"20","author":"Van den Berg","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jbspin.2008.04.005","article-title":"Shifting the imbalance from Th1\/Th2 to Th17\/treg: the changing rheumatoid arthritis paradigm","volume":"75","author":"Boissier","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(88)90185-7","article-title":"Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis","volume":"2","author":"Eastgate","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.10.011_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/ard.51.6.731","article-title":"Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial fluid","volume":"51","author":"Kahle","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.011_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/art.1780380511","article-title":"Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications","volume":"38","author":"Chikanza","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib13","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.4049\/jimmunol.156.9.3558","article-title":"Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy","volume":"156","author":"Otani","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib14","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1073\/pnas.0502854102","article-title":"Gene transfer to human joints: progress toward a gene therapy of arthritis","volume":"102","author":"Evans","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2009.10.011_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/ar2438","article-title":"The human anti-Il-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis","volume":"10","author":"Alten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2009.10.011_bib16","first-page":"81","article-title":"Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders","volume":"11","author":"Church","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.jbspin.2009.10.011_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ncprheum0959","article-title":"Rilonacept in cryopyrin-associated periodic syndromes: the beginning of longer-acting interleukin-1 antagonism","volume":"5","author":"Church","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nbt0508-485b","article-title":"IL-1 trap go-ahead","volume":"26","author":"Ratner","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib19","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib20","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1043-4666(92)90078-6","article-title":"Pharmacokinetics, safety, and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans","volume":"4","author":"Granowitz","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-148-2-200801150-00192","article-title":"Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis","volume":"148","author":"Donahue","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2009.10.011_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kem072","article-title":"The efficacy of inhibiting tumour necrosis factor \u03b1 and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons","volume":"46","author":"Nixon","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2009.10.011_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jbspin.2006.10.006","article-title":"What is the role for interleukin-1 receptor antagonist in rheumatic disease?","volume":"74","author":"Lequerr\u00e9","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","article-title":"Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice","volume":"191","author":"Horai","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2009.10.011_bib26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200009073431011","article-title":"The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1","volume":"343","author":"Dinarello","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.10.011_bib27","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.4049\/jimmunol.159.7.3604","article-title":"Constitutive intra-articular expression of human IL-1\u03b2 following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis","volume":"159","author":"Ghivizzani","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib28","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/art.23957","article-title":"Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice","volume":"58","author":"Koenders","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1997","article-title":"Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation","volume":"7","author":"Mariathasan","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","article-title":"Primer: inflammasomes and interleukin 1\u03b2 in inflammatory disorders","volume":"4","author":"Church","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jbspin.2007.07.005","article-title":"Auto-inflammatory syndromes: diagnosis and treatment","volume":"74","author":"Stankovic","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keh652","article-title":"Positive clinical and biochemical responses to anakinra in a 3-year-old patient with cryopyrin-associated periodic syndrome (CAPS)","volume":"44","author":"Ramos","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2009.10.011_bib33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.10.011_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jbspin.2007.01.032","article-title":"Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra","volume":"74","author":"Gerard","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra","volume":"66","author":"Kuijk","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.011_bib36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jbspin.2008.04.001","article-title":"Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine","volume":"75","author":"Roldan","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jbspin.2006.11.018","article-title":"Effectiveness of anti-IL-1 in Schnitzler's syndrome","volume":"74","author":"Klemmer","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2009.10.011_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.011_bib40","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jbspin.2007.04.004","article-title":"The inflammasome, autoinflammatory diseases, and gout","volume":"74","author":"P\u00e9trilli","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib42","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI29404","article-title":"Gout: new insights into an old disease","volume":"116","author":"Martinon","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2009.10.011_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2009.10.011_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/art.23119","article-title":"Successful treatment of resistant pseudogout with anakinra","volume":"58","author":"McGonagle","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","article-title":"Primer: inflammasomes and interleukin 1beta in inflammatory disorders","volume":"4","author":"Church","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jbspin.2009.10.011_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","article-title":"Sulfasalazine in the treatment of spondyloarthritides","volume":"38","author":"Dougados","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab \u2013 a double-blind placebo controlled multicenter trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.10.011_bib48","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","article-title":"Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial","volume":"48","author":"Davis","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/40.12.1359","article-title":"A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis","volume":"40","author":"McGarry","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2009.10.011_bib50","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/ard.2004.020800","article-title":"Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study","volume":"63","author":"Tan","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.011_bib51","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/art.1780370917","article-title":"Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus","volume":"37","author":"Blakemore","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/art.1780380806","article-title":"Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus: enhanced production by monocytes and correlation with disease activity","volume":"38","author":"Suzuki","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.011_bib53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1191\/0961203304lu1047cr","article-title":"IL-1RA in refractory systemic lupus erythematosus","volume":"13","author":"Moosig","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2009.10.011_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.2004.025858","article-title":"Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis","volume":"64","author":"Ostendorf","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.011_bib55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2169\/internalmedicine.39.128","article-title":"Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis","volume":"39","author":"Son","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2009.10.011_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jbspin.2007.07.010","article-title":"Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: a case report","volume":"75","author":"Furlan","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.10.011_bib57","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jbspin.2008.02.011","article-title":"Efficacy of anakinra in a patient with refractory relapsing polychondritis","volume":"75","author":"Wendling","year":"2008","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T09:58:11Z","timestamp":1685354291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1297319X09002164"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2009.10.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}